Skip to Content

Logo 202 Logo 202 (Methylphenidate Hydrochloride Extended-Release (LA) 40 mg)

Pill with imprint Logo 202 Logo 202 is Blue & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 40 mg. It is supplied by Mayne Pharma.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression; fatigue; obesity (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo 202 Logo 202

Methylphenidate hydrochloride extended-release (LA) 40 mg Logo 202 Logo 202
Methylphenidate hydrochloride extended-release (LA) 40 mg Logo 202 Logo 202
Methylphenidate hydrochloride extended-release (LA) 40 mg Logo 202 Logo 202

Methylphenidate Hydrochloride Extended-Release (LA)

Imprint:
Logo 202 Logo 202
Strength:
40 mg
Color:
Blue & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Mayne Pharma
Manufacturer:
Catalent Pharma Solutions, LLC
National Drug Code (NDC):
51862-0265

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide